FDA Inspection 1275186 — Qilu SYNVA Pharmaceutical Co. Ltd
The FDA completed an inspection of Qilu SYNVA Pharmaceutical Co. Ltd on May 16, 2025 in Dezhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 16, 2025
- Fiscal Year
- 2025
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Dezhou (China)